RFG Advisory’s iShares Biotechnology ETF IBB Stock Holding History

RFG Advisory’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$349K	Buy	+1,837	New	+$316K	0.01%	902
2022 Q4	–	Sell	-1,664	Closed	-$217K	–	637
2022 Q3	$217K	Sell	1,664 -36	-2%	-$4.47K	0.01%	568
2022 Q2	$223K	Buy	1,700 +47	+3%	+$5.58K	0.01%	516
2022 Q1	$215K	Buy	1,653 +89	+6%	+$11.6K	0.01%	479
2021 Q4	$239K	Buy	+1,564	New	+$242K	0.02%	434
2015 Q2	–	Sell	-11,235	Closed	-$1.29M	–	169
2015 Q1	$1.29M	Buy	+11,235	New	+$1.24M	0.98%	12

Other funds holding IBB

GIC

Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return

FNFDCM

Folger Nolan Fleming Douglas Capital Management Washington, District of Columbia $1.22B AUM 34.81% 1-Year Est. Return

Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return

RFA

Reyes Financial Architecture San Diego, California $179M AUM 31.17% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

NRS

Neville Rodie & Shaw New York $1.55B AUM 46.95% 1-Year Est. Return

MCG

McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

SCA

Southern Capital Advisors Jackson, Tennessee $239M AUM 22.42% 1-Year Est. Return

RFG Advisory's IBB Position: Q2 2026 in Review

RFG Advisory opened a new position in iShares Biotechnology ETF (IBB) in Q2 2026: 1,837 shares worth $349K. The stake represents 0.01% of the portfolio and ranks #902 among its holdings. This is a return to the name: RFG Advisory previously reported a position in IBB as recently as Q3 2022.

RFG Advisory first reported a position in IBB in Q1 2015 and has held it in 6 quarters since. The position peaked at $1.29M in Q1 2015. 158 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

RFG Advisory held 1,837 shares of iShares Biotechnology ETF worth $349K as of Q2 2026.
iShares Biotechnology ETF was a new RFG Advisory position in Q2 2026.
iShares Biotechnology ETF made up 0.01% of RFG Advisory's portfolio in Q2 2026, its #902 holding.
RFG Advisory first reported a position in iShares Biotechnology ETF in Q1 2015 and has held it in 6 quarters since.
RFG Advisory's iShares Biotechnology ETF position peaked at $1.29M in Q1 2015.
158 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on RFG Advisory's 13F filing for Q2 2026, filed 15 Jul 2026.